Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia

BACKGROUND: In Zambia the first-line treatment for uncomplicated malaria is artemisinin combination therapy (ACT), with artemether-lumefantrine currently being used. However, the antifolate regimen, sulphadoxine-pyrimethamine (SP), remains the treatment of choice in children weighing less than 5 kg...

Descripción completa

Detalles Bibliográficos
Autores principales: Mkulama, Mtawa AP, Chishimba, Sandra, Sikalima, Jay, Rouse, Petrica, Thuma, Philip E, Mharakurwa, Sungano
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2412897/
https://www.ncbi.nlm.nih.gov/pubmed/18495008
http://dx.doi.org/10.1186/1475-2875-7-87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2412897/
https://www.ncbi.nlm.nih.gov/pubmed/18495008
http://dx.doi.org/10.1186/1475-2875-7-87

Ejemplares similares